Guaifenesin and Codeine Phosphate Oral Solution USP
Superpotent; sodium benzoate preservative
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
CGMP Deviations: use of non-food grade lubricant in mixing vessel.
Cause type: cGMP deviation
Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.
Safe Tussin DM Cough + Chest Congestion (Dextromethorphan HBr/ Cough Suppressant Guaifenesin/Expectorant), packaged in 4.0 FL OZ(118mL), 2020 Kramer Laboratories, Inc. Bridgewater, NJ 08807
Drug: Guaifenesin
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Superpotent; sodium benzoate preservative
CGMP Deviations: Released product should have been rejected.
Failed Impurity/Degradation Specifications
Failed Impurity/Degradation Specifications
Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
CGMP Deviations: use of non-food grade lubricant in mixing vessel.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.